Comments on: Monday Deal Review: June 29, 2009 http://crossborderbiotech.ca/2009/06/29/monday-deal-review-june-29-2009/ Biotechnology, Health and Business in Canada, the United States and Worldwide Mon, 23 Aug 2010 02:23:29 +0000 hourly 1 http://wordpress.com/ By: Monday Biotech Deal Review: October 25, 2009 « The Cross-Border Biotech Blog http://crossborderbiotech.ca/2009/06/29/monday-deal-review-june-29-2009/comment-page-1/#comment-1051 Monday Biotech Deal Review: October 25, 2009 « The Cross-Border Biotech Blog Mon, 26 Oct 2009 13:51:07 +0000 http://crossborderbiotech.ca/?p=2441#comment-1051 [...] Zentaris Inc. (NASDAQ:  AEZS) (TSX: AEZ) followed June’s $10 million offering with another $5.5 million this week: 4.58 million common shares at $1.20 per share plus 5-year [...] [...] Zentaris Inc. (NASDAQ:  AEZS) (TSX: AEZ) followed June’s $10 million offering with another $5.5 million this week: 4.58 million common shares at $1.20 per share plus 5-year [...]

]]> By: Monday Deal Review: July 27, 2009 « The Cross-Border Biotech Blog http://crossborderbiotech.ca/2009/06/29/monday-deal-review-june-29-2009/comment-page-1/#comment-686 Monday Deal Review: July 27, 2009 « The Cross-Border Biotech Blog Mon, 27 Jul 2009 04:09:32 +0000 http://crossborderbiotech.ca/?p=2441#comment-686 [...] (NASDAQ: OGXI) didn’t waste much time using the new shelf they put up last month, announced and closed a $9.5 million registered direct offering of 475,000 common shares. The $20 [...] [...] (NASDAQ: OGXI) didn’t waste much time using the new shelf they put up last month, announced and closed a $9.5 million registered direct offering of 475,000 common shares. The $20 [...]

]]> By: Monday Deal Review: July 20, 2009 « The Cross-Border Biotech Blog http://crossborderbiotech.ca/2009/06/29/monday-deal-review-june-29-2009/comment-page-1/#comment-653 Monday Deal Review: July 20, 2009 « The Cross-Border Biotech Blog Mon, 20 Jul 2009 11:05:45 +0000 http://crossborderbiotech.ca/?p=2441#comment-653 [...] Securities Inc. gets $8,030 plus 50,190 warrants as finders fees. PharmaGap also noted that June’s shares-for-debt deal with the NRC has TSX-V approval but is waiting for sign-off from NRC’s legal and financial services [...] [...] Securities Inc. gets $8,030 plus 50,190 warrants as finders fees. PharmaGap also noted that June’s shares-for-debt deal with the NRC has TSX-V approval but is waiting for sign-off from NRC’s legal and financial services [...]

]]>